Operating Cash Flow
Edwards Lifesciences Operating Cash Flow decreased by 90.3% to $43.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 84.4%, from $280.40M to $43.80M. Over 3 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a -2.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Consistently high operating cash flow indicates a healthy, self-sustaining business capable of funding its own growth and returning capital to shareholders.
Detailed definition
Net cash from operating activities measures the total amount of cash generated by a company's core business operations....
Peer comparison
Investors often compare this to capital expenditures to calculate Free Cash Flow, a primary valuation metric for mature tech giants.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $526.10M | $531.90M | $373.60M | $293.30M | $332.20M | $309.90M | $282.80M | $314.10M | $33.60M | $411.50M | $136.60M | -$53.50M | $371.50M | $351.80M | $280.40M | $290.20M | $573.70M | $450.90M | $43.80M |
| QoQ Change | — | +1.1% | -29.8% | -21.5% | +13.3% | -6.7% | -8.7% | +11.1% | -89.3% | >999% | -66.8% | -139.2% | +794.4% | -5.3% | -20.3% | +3.5% | +97.7% | -21.4% | -90.3% |
| YoY Change | — | — | — | — | -36.9% | -41.7% | -24.3% | +7.1% | -89.9% | +32.8% | -51.7% | -117.0% | >999% | -14.5% | +624.1% | -21.9% | +63.1% | — | -84.4% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's operating cash flow?
- Edwards Lifesciences (EW) reported operating cash flow of $43.80M in Q1 2026.
- How has Edwards Lifesciences's operating cash flow changed year-over-year?
- Edwards Lifesciences's operating cash flow decreased by 84.4% year-over-year, from $280.40M to $43.80M.
- What is the long-term trend for Edwards Lifesciences's operating cash flow?
- Over 3 years (2021 to 2025), Edwards Lifesciences's operating cash flow has grown at a -2.7% compound annual growth rate (CAGR), from $1.73B to $1.60B.
- What does operating cash flow mean?
- The actual amount of cash a company brings in from its day-to-day business activities.